U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145229) titled 'Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare' on Aug. 13.
Brief Summary: A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy of ABP-745 in reducing pain and swelling compared with standard colchicine treatment and placebo will be evaluated in participants with acute gout. The primary efficacy measurement will be pain score after treatment.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Acute Gouty Arthritis
Gout Flare
Gout Flares
Acute Gout Flare
Intervent...